Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

This biotech making precision medicines for cancer could nearly triple, says JPMorgan

Kura Oncology's pipeline of drugs show promise for the biotech stock.

This biotech making precision medicines for cancer could nearly triple, says JPMorgan

Published October 1, 2026 · Category: Finance

Overview

Kura Oncology's pipeline of drugs show promise for the biotech stock.

Source

Originally published at www.cnbc.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.